Wilson Sonsini Goodrich & Rosati advised Versant Ventures and New Enterprise Associates on the deal.Nexo Therapeutics (Nexo) announced it has emerged from stealth with $60 million Series…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
